ArticleCureus2025
Primary Breast Angiosarcoma: A Case Report.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Primary breast angiosarcomas are extremely rare and aggressive tumors that originate from the inner lining of blood and lymphatic vessels in the breast. They are typically associated with a poor prognosis and have a strong tendency to metastasize. This report describes the case of a 57-year-old woman who detected a suspicious mass in her left breast during a routine self-examination. She initially underwent a lumpectomy, followed by a prophylactic mastectomy one year later. The tumor was identified as a well-differentiated primary breast angiosarcoma. The patient is currently being closely monitored and may require further treatment, including reconstructive surgery and adjuvant therapy. This case highlights the critical role of early detection and prompt intervention in enhancing the outcomes for patients with primary breast angiosarcomas. Despite their rarity, these tumors demand timely and comprehensive care to minimize the risk of recurrence and metastatic disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.